MEM-288

· Memgen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEM-288, covering 2025-08-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]